More than 16 countries are participating in a project in which 50 patients in Israel are being treated with a new drug to combat Alzheimer’s disease, according to the Israeli daily Ha’aretz. The patients will be treated with the drug, AIT-0-82, for six months, with the option of continuing treatment for an additional year, the paper reported.
The Archive of the Jewish Telegraphic Agency includes articles published from 1923 to 2008. Archive stories reflect the journalistic standards and practices of the time they were published.
